Joydeep Bhadury

Instructor, Institute for Stem Cell Biology and Regenerative Medicine

Academic Appointments

Instructor, Institute for Stem Cell Biology and Regenerative Medicine

Honors & Awards

International Postdoc Grant (2017-0034, Spring 2017), Swedish Research Council (June 2017)
PhD thesis of the year 2016 for Institute of Clinical Sciences, University of Gothenburg, The Sahlgrenska Academy, University of Gothenburg , Sweden (May 2017)
Assar Gabrielssons Best PhD Thesis Award 2017 in Experimental Research, Stiftelsen Assar Gabrielssons Fond, Sweden (May 2017)

All Publications

Profiles With Related Publications

close
Ash A. Alizadeh, MD/PhD

Moghadam Family Professor
Clinical Focus
Cancer > Lymphoma, Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Burkitt Lymphoma, Follicular Lymphoma, Diffuse Large-Cell Lymphomas, Leukemia, Hairy Cell, Lymphoma, B-Cell, Marginal Zone, Hodgkin Disease, Medical Oncology
Research Interests
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

355 Total Publications
close
Hyatt Balke Want

Postdoctoral Scholar, Stanford Cancer Center

7 Total Publications
close
James D. Brooks

Keith and Jan Hurlbut Professor
Clinical Focus
Cancer > Urologic Oncology, Prostate cancer screening, Prostate cancer - localized, Prostate cancer active surveillance, Urology
Research Interests
We use genomic approaches to identify disease biomarkers. We are most interested in translating biomarkers into clinical practice in urological diseases with a particular focus in cancer.

334 Total Publications
close
Patrick O. Brown

Professor of Biochemistry, Emeritus
Research Interests
Dr. Brown, currently an emeritus professor, is CEO and founder of Impossible Foods, a company dedicated to replacing the world's most destructive technology - the use of animals to transform plant biomass into meat, fish and dairy foods - by developing a new and better way to produce the world's most delicious, nutritious and affordable meats, fish and dairy foods directly from plants. Visit impossiblefoods.com for more information.

323 Total Publications
close
Dalton Christopher Brunson

MD Student with Scholarly Concentration in Clinical Research, expected graduation Spring 2025 Masters Student in Epidemiology and Clinical Research, admitted Autumn 2021

8 Total Publications
close
Michael F. Clarke, M.D.

Karel H. and Avice N. Beekhuis Professor of Cancer Biology
Research Interests
Dr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.

180 Total Publications
close
Steven M. Corsello

Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology
Clinical Focus
Medical Oncology

21 Total Publications
close
Oana M. Enache

Ph.D. Student in Biomedical Informatics, admitted Autumn 2021

10 Total Publications
close
Alice C. Fan

Assistant Professor of Medicine (Oncology) and, by courtesy, of Urology
Clinical Focus
Cancer > Urologic Oncology, Medical Oncology, Urologic Neoplasms, Kidney Cancer, Translational Research, Biomedical, Molecular Targeted Therapy, Nano-proteomics, Clinical Trials as Topic
Research Interests
Dr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.

92 Total Publications
close
Dean W. Felsher

Professor of Medicine (Oncology) and of Pathology
Research Interests
My laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.

214 Total Publications
close
Andrew Gentles

Assistant Professor (Research) of Pathology, of Medicine (BMIR) and, by courtesy, of Biomedical Data Science
Research Interests
Computational systems biology of human disease. Particular focus on integration of high-throughput datasets with each other, and with phenotypic information and clinical outcomes.

107 Total Publications
close
Amato J. Giaccia

Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus
Research Interests
During the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.

403 Total Publications